Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
Open Access
- 1 March 2000
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 2 (1) , 107-112
- https://doi.org/10.1016/s1388-9842(00)00053-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart FailureCirculation, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Carvedilol for Heart Failure: Clinical Trials in ProgressHeart Failure Reviews, 1999
- Clinical Effects of β-Adrenergic Blockade in Chronic Heart FailureCirculation, 1998
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Published by Elsevier ,1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Design of the Beta-Blocker Evaluation Survival Trial (BEST)The American Journal of Cardiology, 1995
- Losartan in Heart FailureCirculation, 1995
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991